Downsview Capital
investment firm
About
Downsview Capital, Inc. is a Illinois-based investment advisor that manages the private equity funds including Cranshire Capital, L.P.
- Deerfield,Illinois,United States
Highlights
Details
- Operating Status
- Active
- Investor Type
- PE
Downsview Capital, Inc. is a Illinois-based investment advisor that manages the private equity funds including Cranshire Capital, L.P.
Investments
Number of Investments
Number of Lead Investments
6
0
Downsview Capital has made 6 investments. Their most recent investment was on
Sep 24, 2010, when Cascadian Therapeutics raised $14.90M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 24, 2010
Cascadian Therapeutics
|
Post-IPO Equity | $14.90M | Biotechnology | — |
|
Jul 2, 2010
Soligenix
|
Series Unknown | $5.90M | Biopharma | — |
|
Feb 24, 2010
SinoHub
|
Series Unknown | $4.61M | Electronics | — |
|
Aug 4, 2009
Agenus
|
Post-IPO Equity | $10M | Biotechnology | — |
|
Dec 13, 2005
EUSA Pharma
|
Series Unknown | $12.53M | Biotechnology | — |
Exits
Downsview Capital has had 5 exits. Downsview Capital most notable exits include EUSA Pharma , Soligenix
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 2, 2021 | EUSA Pharma | M&A | Biotechnology | Detail |
| Dec 13, 2016 | Soligenix | IPO | Biopharma | Detail |
| Sep 24, 2008 | Pharmacopeia | M&A | Biopharma | Detail |
| Feb 11, 2000 | Agenus | IPO | Biotechnology | Detail |
| Nov 29, 1991 | Cascadian Therapeutics | M&A | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
